Abstract
This paper identifies and discusses current marketing practice in the pharmaceutical sector, as it relates to therapeutic pharmaceuticals. It examines the potential risks associated with certain marketing practices, such as the impact of misleading advertising and the possibility of disease mongering. The methods currently used to regulate industry promotion practice are critiqued and suggestions are made for improvements, including a move from industry self-regulation to an independently monitored code of practice for pharmaceutical marketing.
| Original language | English |
|---|---|
| Pages (from-to) | 92-103 |
| Number of pages | 12 |
| Journal | Problems and Perspectives in Management |
| Volume | 2 |
| Issue number | 4 |
| Publication status | Published - 2004 |
Keywords
- Advertising
- Pharmaceutical marketing